Diagnostics and biomarkers companies develop technologies that detect, monitor and predict disease using biological markers, laboratory testing and analytical platforms. These tools play a critical role in modern healthcare and precision medicine.
This category includes companies working on:
Browse 252 UK diagnostics and biomarkers companies below.
Portable PCR diagnostic platforms and test kits for veterinary use
ZYTCA Animal Health is a veterinary diagnostics company developing portable point-of-care PCR platforms for rapid disease detection in animals. Using isothermal amplification and lateral flow immunoassay technology, its devices deliver qualitative results in under 30 minutes from unextracted clinical samples, with a…
Molecular biology reagents and enzymes for diagnostic and biotech applications
Apto-Gen is a UK manufacturer of high-performance enzymes and molecular biology reagents for integration into PCR, qPCR, NGS, and isothermal amplification assays. Its products serve human diagnostics, veterinary diagnostics, food safety, and environmental testing customers, and are designed for direct integration into…
Clinical genomic decision support software for rare disease and oncology
Congenica is a clinical genomic interpretation platform spun out of the Wellcome Sanger Institute. Its software supports variant analysis and clinical reporting across rare disease, oncology and infectious disease, integrating whole genome sequencing data with phenotypic information to generate actionable diagnostic…
DNA nanoprobes for intracellular biomarker profiling in neurodegeneration
Esya Labs is a precision biomarker company using patented DNA nanoprobes to measure ion signatures within intracellular organelles including endosomes and lysosomes. The technology enables ratiometric quantification of subcellular chemical states in living cells, with applications in early detection of…
University genomics core facility for sequencing, single-cell and spatial analysis
The Imperial BRC Genomics Facility is a university core facility supporting translational genomics research. It provides next-generation sequencing, single-cell genomics, spatial transcriptomics and proteomics, alongside experimental design, library preparation and bioinformatics analysis. Its services are used to…
Specialist biomarker and bioanalytical CRO for clinical drug development
Synexa Life Sciences is a specialist contract research organisation providing biomarker and bioanalytical laboratory services to global biopharmaceutical companies. The company develops, validates, and delivers custom assays supporting clinical trials and translational studies, with expertise spanning LC-MS/MS…
Breath-based volatile organic compound test for multi-cancer detection
SpiraCheck is a biotechnology company developing a non-invasive breath test for the early detection of gastrointestinal cancers. Patients exhale into a collection device; the sample is analysed in the laboratory by mass spectrometry to quantify volatile organic compounds, and a patented algorithm interprets the…
Veterinary ELISA diagnostic kits and immunoassay reagents
MV Diagnostics develops and supplies veterinary immunodiagnostic kits and laboratory reagents for animal disease testing. Its product portfolio includes ELISA assays, recombinant proteins and peptides used in research and veterinary diagnostic laboratories. The company develops immunoassays and multiplex testing…
AI echocardiography platform for heart failure detection
Ultromics is an Oxford University spin-out developing AI-powered software that analyses routine echocardiogram images to detect complex cardiac conditions. Its cloud-based platform holds multiple FDA clearances and CE marks for heart failure with preserved ejection fraction and cardiac amyloidosis screening. The…
Integrated sample collection and rapid molecular diagnostic devices
ReadyGo Diagnostics develops disposable sample-collection and preparation devices for rapid diagnostic testing. Its technology combines swab collection and lysis chemistry in a single unit and is designed to work with lateral flow, molecular and immunoassay formats. It also supports rapid isothermal molecular tests…
Rapid point-of-care bacterial diagnostics and antibiotic susceptibility testing
FluoretiQ Limited is a diagnostics company developing rapid point-of-care tools for bacterial identification and antibiotic susceptibility testing to support antimicrobial stewardship. Its platform uses functionalised nanoparticles and machine learning to identify and quantify bacterial pathogens from clinical samples…
Specialist histology and immunohistochemistry CRO
HistologiX is a GLP and GCP accredited contract research organisation specialising in tissue-based biomarker analysis for the pharmaceutical and biotechnology industries. The company provides histology, immunohistochemistry, immunofluorescence, and digital pathology services across preclinical toxicology, regulatory…
AI-driven microRNA biomarker diagnostics for early veterinary disease detection
MI:RNA Diagnostics is a UK-based developer of a diagnostic platform combining microRNA biomarker panels with a proprietary artificial intelligence model to detect early-stage disease in animals. The company's flagship application targets cardiac disease in cats and dogs, with further research into Johne's disease…
DNA nanorobot platform for nucleic acid detection and bioanalysis
Nanovery is a biotechnology company developing a patented Nucleic Acid Nanorobotics (NANs) platform for enzyme-free detection and quantification of nucleic acid targets. Synthetic DNA nanorobots generate fluorescent signals in response to specific sequences, enabling direct quantification of antisense…
Rapid antimicrobial susceptibility testing platform for urinary infections
Astratus is an instruments company developing a rapid antimicrobial susceptibility testing platform for clinical microbiology. Its microcapillary cassette and reader system delivers digital susceptibility results directly from urine samples in under six hours, compared to the two to three days required by standard…
Bioanalytical, DMPK and analytical sciences CRO for drug development
Resolian UK is a contract research organisation specialising in bioanalysis, drug metabolism and pharmacokinetics, and analytical sciences services for pharmaceutical and biotechnology clients. Operating from purpose-built laboratories in Fordham, Cambridgeshire and Sandwich, Kent, the company delivers GxP and non-GMP…
MALDI-TOF mass spectrometry instruments for clinical microbial identification
Ascend Diagnostics is a developer of MALDI-TOF mass spectrometry systems for high-throughput clinical diagnostic laboratories. Its platform identifies bacteria and other microorganisms from patient samples by measuring their characteristic protein profiles and matching them against a microbial reference database,…
Molecular diagnostics, biomarker research and genomic analysis services
BioMarker Solutions is a diagnostics and research services company supporting biomarker discovery, validation and molecular testing. Its activities cover genomic analysis, oncology diagnostics, clinical trial support, digital pathology and laboratory information systems. The group offers NGSuite software for…
Synthetic chemical receptor R&D for implantable glucose biosensors
Lifecare Chemistry Ltd is a UK R&D subsidiary of Norwegian medical sensor company Lifecare ASA, established to develop and own proprietary analyte-specific synthetic receptors for use in Lifecare's implantable continuous glucose monitoring technology. Working in collaboration with researchers at the University of…
3D genomics platform for blood-based clinical diagnostics and precision medicine
Oxford BioDynamics develops blood-based diagnostic tests and precision medicine tools using its proprietary 3D genomics platform. The technology analyses chromosome conformation to identify epigenomic biomarkers linked to disease, prognosis and treatment response. Commercial products include tests for immune…